Research ArticleArticle
Inhibition of CYP2C19 and CYP3A4 by Omeprazole Metabolites and Their Contribution to Drug-Drug Interactions
Yoshiyuki Shirasaka, Jennifer E. Sager, Justin D. Lutz, Connie Davis and Nina Isoherranen
Drug Metabolism and Disposition July 2013, 41 (7) 1414-1424; DOI: https://doi.org/10.1124/dmd.113.051722
Yoshiyuki Shirasaka
Department of Pharmaceutics, School of Pharmacy (Y.S., J.E.S., J.D.L., N.I.), and Division of Nephrology, Department of Medicine, School of Medicine (C.D.) University of Washington, Seattle, Washington; and Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Japan (Y.S.)
Jennifer E. Sager
Department of Pharmaceutics, School of Pharmacy (Y.S., J.E.S., J.D.L., N.I.), and Division of Nephrology, Department of Medicine, School of Medicine (C.D.) University of Washington, Seattle, Washington; and Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Japan (Y.S.)
Justin D. Lutz
Department of Pharmaceutics, School of Pharmacy (Y.S., J.E.S., J.D.L., N.I.), and Division of Nephrology, Department of Medicine, School of Medicine (C.D.) University of Washington, Seattle, Washington; and Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Japan (Y.S.)
Connie Davis
Department of Pharmaceutics, School of Pharmacy (Y.S., J.E.S., J.D.L., N.I.), and Division of Nephrology, Department of Medicine, School of Medicine (C.D.) University of Washington, Seattle, Washington; and Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Japan (Y.S.)
Nina Isoherranen
Department of Pharmaceutics, School of Pharmacy (Y.S., J.E.S., J.D.L., N.I.), and Division of Nephrology, Department of Medicine, School of Medicine (C.D.) University of Washington, Seattle, Washington; and Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Japan (Y.S.)

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
CYP2C19 and CYP3A4 Inhibition by Omeprazole Metabolites
Yoshiyuki Shirasaka, Jennifer E. Sager, Justin D. Lutz, Connie Davis and Nina Isoherranen
Drug Metabolism and Disposition July 1, 2013, 41 (7) 1414-1424; DOI: https://doi.org/10.1124/dmd.113.051722
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement